Literature DB >> 8650576

Adenosine diphosphate as an intracellular regulator of insulin secretion.

C G Nichols1, S L Shyng, A Nestorowicz, B Glaser, J P Clement, G Gonzalez, L Aguilar-Bryan, M A Permutt, J Bryan.   

Abstract

Adenosine triphosphate (ATP)-sensitive potassium (KATP) channels couple the cellular metabolic state to electrical activity and are a critical link between blood glucose concentration and pancreatic insulin secretion. A mutation in the second nucleotide-binding fold (NBF2) of the sulfonylurea receptor (SUR) of an individual diagnosed with persistent hyperinsulinemic hypoglycemia of infancy generated KATP channels that could be opened by diazoxide but not in response to metabolic inhibition. The hamster SUR, containing the analogous mutation, had normal ATP sensitivity, but unlike wild-type channels, inhibition by ATP was not antagonized by adenosine diphosphate (ADP). Additional mutations in NBF2 resulted in the same phenotype, whereas an equivalent mutation in NBF1 showed normal sensitivity to MgADP. Thus, by binding to SUR NBF2 and antagonizing ATP inhibition of KATP++ channels, intracellular MgADP may regulate insulin secretion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8650576     DOI: 10.1126/science.272.5269.1785

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  181 in total

1.  ATP interaction with the open state of the K(ATP) channel.

Authors:  D Enkvetchakul; G Loussouarn; E Makhina; C G Nichols
Journal:  Biophys J       Date:  2001-02       Impact factor: 4.033

2.  Regulation of ATP-sensitive potassium channel function by protein kinase A-mediated phosphorylation in transfected HEK293 cells.

Authors:  Y F Lin; Y N Jan; L Y Jan
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

3.  The kinetic and physical basis of K(ATP) channel gating: toward a unified molecular understanding.

Authors:  D Enkvetchakul; G Loussouarn; E Makhina; S L Shyng; C G Nichols
Journal:  Biophys J       Date:  2000-05       Impact factor: 4.033

4.  Modulation of nucleotide sensitivity of ATP-sensitive potassium channels by phosphatidylinositol-4-phosphate 5-kinase.

Authors:  S L Shyng; A Barbieri; A Gumusboga; C Cukras; L Pike; J N Davis; P D Stahl; C G Nichols
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

5.  The role of lysine 185 in the kir6.2 subunit of the ATP-sensitive channel in channel inhibition by ATP.

Authors:  F Reimann; T J Ryder; S J Tucker; F M Ashcroft
Journal:  J Physiol       Date:  1999-11-01       Impact factor: 5.182

6.  On the mechanism of ADP-induced alteration of sulphonylurea sensitivity in cardiac ATP-sensitive K(+) channels.

Authors:  A Miyamura; M Kakei; K Ichinari; M Okamura; N Oketani; C Tei
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

7.  The I182 region of k(ir)6.2 is closely associated with ligand binding in K(ATP) channel inhibition by ATP.

Authors:  L Li; J Wang; P Drain
Journal:  Biophys J       Date:  2000-08       Impact factor: 4.033

8.  Adenylate kinase phosphotransfer communicates cellular energetic signals to ATP-sensitive potassium channels.

Authors:  A J Carrasco; P P Dzeja; A E Alekseev; D Pucar; L V Zingman; M R Abraham; D Hodgson; M Bienengraeber; M Puceat; E Janssen; B Wieringa; A Terzic
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

9.  Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1.

Authors:  H Huopio; F Reimann; R Ashfield; J Komulainen; H L Lenko; J Rahier; I Vauhkonen; J Kere; M Laakso; F Ashcroft; T Otonkoski
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

10.  Cellular remodeling in heart failure disrupts K(ATP) channel-dependent stress tolerance.

Authors:  Denice M Hodgson; Leonid V Zingman; Garvan C Kane; Carmen Perez-Terzic; Martin Bienengraeber; Cevher Ozcan; Richard J Gumina; Darko Pucar; Fergus O'Coclain; Douglas L Mann; Alexey E Alekseev; Andre Terzic
Journal:  EMBO J       Date:  2003-04-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.